There are 2789 resources available
367P - The analysis of STAG2 variants in Chinese adult patients with glioma
Presenter: yongli bo
Session: ePoster Display
368P - Characteristics of deleterious germline mutations in glioma patients
Presenter: Gousiyi Wang
Session: ePoster Display
425P - Cetuximab could be administered once every two weeks instead of once weekly
Presenter: sarah Lobet
Session: ePoster Display
426P - Spotlight on refractory metastatic colorectal cancer (refMCRC): Role of prognostic characteristics in the continuum of care
Presenter: Augusto Valdivia
Session: ePoster Display
427P - Real world data of trifluridine/tipiracil in refractory mCRC: A multicenter experience at four GEODA Spanish hospitals
Presenter: Julia Martinez Perez
Session: ePoster Display
428P - Retrospective cohort study of low-dose apatinib plus S-1 versus regorafenib and fruquintinib for refractory metastatic colorectal cancer
Presenter: Hong Qiu
Session: ePoster Display
Resources:
Abstract
375P - Clinical outcomes of targeting therapy with BRAF/MEK inhibitors in patients with BRAF V600-mutated brain tumors
Presenter: Marta Mejías Trueba
Session: ePoster Display
376P - Nucleolin and its prognostic value in pediatric patients with intracranial ependymoma: A systematic review and meta-analysis
Presenter: Jeremiah Wijaya
Session: ePoster Display
430P - Learning from FOCUS4: A molecularly stratified adaptive trial platform in metastatic colorectal cancer
Presenter: Janet Graham
Session: ePoster Display
Resources:
Abstract
431P - The FOCUS4-N trial results and individual patient data meta-analysis (IPDM) of maintenance therapy versus active monitoring for patients with metastatic colorectal cancer (mCRC)
Presenter: Richard Adams
Session: ePoster Display